SANTEN PHARMA. financial statements, including revenue, expenses, profit, and loss

The total revenue of SZD for the last quarter is 494.58 M EUR, and it's 6.41% higher compared to the previous quarter. The net income of Q3 23 is 47.05 M EUR.